サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1418378

胎児のcell-free DNA検査市場レポート：2030年までの動向、予測、競合分析

Cell Free Fetal DNA Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

胎児のcell-free DNA検査市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

胎児のcell-free DNA検査の動向と予測

胎児のcell-free DNA検査の世界市場は、2024年から2030年にかけてCAGR 12.3％で成長すると予測されます。この市場の主な促進要因は、遺伝性疾患に対する意識の高まりと、産科における安全でリスクの少ない出生前診断技術への嗜好の高まりです。胎児のcell-free DNA検査の世界市場の将来は、病院やクリニックセンターでの応用における機会によって有望視されています。

胎児のcell-free DNA検査市場の洞察

Lucintelの予測では、染色体異常検出は、様々な染色体異常の検出に広く使用されているため、予測期間中に最も高い成長を示すと予想されます。

北米は、ヘルスケアシステムが発達しており、無細胞DNA検査に関連する様々な疾患の頻度が増加していることから、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場の成長予測は？

A1.胎児のcell-free DNA検査の世界市場は、2024年から2030年にかけてCAGR 12.3％で成長すると予測されています。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、遺伝性疾患に対する意識の高まりと、産科における安全でリスクの少ない出生前診断技術への嗜好の高まりです。

Q3.市場の主要セグメントは？

A3.胎児のcell-free DNA検査市場の将来は、病院およびクリニックセンター市場における機会により有望と思われます。

Q4.市場の主要企業は？

A4.胎児のcell-free DNA検査の主要企業は以下の通りです。

  • The Fetal Medicine Centre
  • Apollo Path labs
  • Ariosa Diagnostics
  • Sequenom Laboratories
  • Laboratory Corporation of America Holdings
  • Personal Genome Diagnostics
  • Premaitha Health
  • Berry Genomics
  • Roche Holdings
  • Trovagene

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、異常染色体数検出は、様々な染色体異常の検出に広く使用されているため、予測期間中に最も高い成長を示すと予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は、ヘルスケアシステムが発達しており、無細胞DNA検査に関連する様々な疾患の頻度が同地域の人口の間で増加しているため、予測期間中に最も高い成長が見られると予想されます。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 胎児のcell-free DNA検査の世界市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 胎児のcell-free DNA検査の世界市場動向（2018～2023年）と予測（2024～2030年）
  • 胎児のcell-free DNA検査の世界市場：種類別
    • 異常染色体数の検出
    • 性別検査
    • 父性遺伝性疾患の検出
    • 親子鑑定
    • その他
  • 胎児のcell-free DNA検査の世界市場：用途別
    • 病院
    • クリニックセンター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の胎児のcell-free DNA検査の世界市場
  • 北米の胎児のcell-free DNA検査市場
  • 欧州の胎児のcell-free DNA検査市場
  • アジア太平洋の胎児のcell-free DNA検査市場
  • その他地域の胎児のcell-free DNA検査市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の胎児のcell-free DNA検査の世界市場の成長機会
    • 用途別の胎児のcell-free DNA検査の世界市場の成長機会
    • 地域別の胎児のcell-free DNA検査の世界市場の成長機会
  • 胎児のcell-free DNA検査の世界市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 胎児のcell-free DNA検査の世界市場の能力拡大
    • 胎児のcell-free DNA検査の世界市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • The Fetal Medicine Centre
  • Apollo Path labs
  • Ariosa Diagnostics
  • Sequenom Laboratories
  • Laboratory Corporation of America Holdings
  • Personal Genome Diagnostics
  • Premaitha Health
  • Berry Genomics
  • Roche Holdings
  • Trovagene
目次

Cell Free Fetal DNA Testing Trends and Forecast

The future of the global cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center applications. The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

A more than 150-page report is developed to help in your business decisions.

Cell Free Fetal DNA Testing by Segment

The study includes a forecast for the global cell free fetal DNA testing by type, application, and region.

Cell Free Fetal DNA Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Abnormal Chromosome Number Detection
  • Gender Testing
  • Paternally Inherited Disorder Detection
  • Paternity Testing
  • Others

Cell Free Fetal DNA Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Clinic Center
  • Others

Cell Free Fetal DNA Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cell Free Fetal DNA Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cell free fetal DNA testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cell free fetal DNA testing companies profiled in this report include-

  • The Fetal Medicine Centre
  • Apollo Path labs
  • Ariosa Diagnostics
  • Sequenom Laboratories
  • Laboratory Corporation of America Holdings
  • Personal Genome Diagnostics
  • Premaitha Health
  • Berry Genomics
  • Roche Holdings
  • Trovagene

Cell Free Fetal DNA Testing Market Insights

Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Features of the Global Cell Free Fetal DNA Testing Market

Market Size Estimates: Cell free fetal DNA testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cell free fetal DNA testing market size by type, application, and region in terms of value ($B).

Regional Analysis: Cell free fetal DNA testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cell free fetal DNA testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cell free fetal DNA testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cell free fetal DNA testing market?

Answer: The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cell free fetal DNA testing market?

Answer: The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

Q3. What are the major segments for cell free fetal DNA testing market?

Answer: The future of the cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center markets.

Q4. Who are the key cell free fetal DNA testing market companies?

Answer: Some of the key cell free fetal DNA testing companies are as follows.

  • The Fetal Medicine Centre
  • Apollo Path labs
  • Ariosa Diagnostics
  • Sequenom Laboratories
  • Laboratory Corporation of America Holdings
  • Personal Genome Diagnostics
  • Premaitha Health
  • Berry Genomics
  • Roche Holdings
  • Trovagene

Q5. Which cell free fetal DNA testing market segment will be the largest in future?

Answer: Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

Q6. In cell free fetal DNA testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cell free fetal DNA testing market by type (abnormal chromosome number detection, gender testing, paternally inherited disorder detection, paternity testing, and others), application (hospital, clinic center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cell Free Fetal DNA Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cell Free Fetal DNA Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cell Free Fetal DNA Testing Market by Type
    • 3.3.1: Abnormal Chromosome Number Detection
    • 3.3.2: Gender Testing
    • 3.3.3: Paternally Inherited Disorder Detection
    • 3.3.4: Paternity Testing
    • 3.3.5: Others
  • 3.4: Global Cell Free Fetal DNA Testing Market by Application
    • 3.4.1: Hospital
    • 3.4.2: Clinic Center
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cell Free Fetal DNA Testing Market by Region
  • 4.2: North American Cell Free Fetal DNA Testing Market
    • 4.2.2: North American Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
  • 4.3: European Cell Free Fetal DNA Testing Market
    • 4.3.1: European Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
    • 4.3.2: European Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
  • 4.4: APAC Cell Free Fetal DNA Testing Market
    • 4.4.1: APAC Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
    • 4.4.2: APAC Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
  • 4.5: ROW Cell Free Fetal DNA Testing Market
    • 4.5.1: ROW Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
    • 4.5.2: ROW Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Type
    • 6.1.2: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Region
  • 6.2: Emerging Trends in the Global Cell Free Fetal DNA Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cell Free Fetal DNA Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Free Fetal DNA Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: The Fetal Medicine Centre
  • 7.2: Apollo Path labs
  • 7.3: Ariosa Diagnostics
  • 7.4: Sequenom Laboratories
  • 7.5: Laboratory Corporation of America Holdings
  • 7.6: Personal Genome Diagnostics
  • 7.7: Premaitha Health
  • 7.8: Berry Genomics
  • 7.9: Roche Holdings
  • 7.10: Trovagene